Sars-Cov2 has been found in the digestive tract, as well as the respiratory tract.Protection of health care workers during surgery has been increased and some guidelinesadvocate for abandoning laparoscopy in COVID19 patients for fear of contamination,evenghtough this does not benefit the patient. However, Sars-Cov2 contamination riskduring visceral surgery remains unknown. Inadequate protection is unnecessary costful andcan be inefficient if too binding. Our hypotheses are that 1) Sars-Cov 2 can travelthrough droplet and air during visceral surgery. 2) Laparoscopy, because of thepneumoperitoneum and its leaks, warrant more air contamination whereas laparotomy warrantmore droplet contamination, which would justified increased protection.
Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.
Air sampling, operating room surfaces sampling and patients' biological fluid sampling
for Sars-Cov2 quantification
Inclusion Criteria:
- Documented Sars-Cov2 infection (nasopharyngeal swab, tracheal sampling, thoracic CT,
serology)
- Need of visceral surgery (laparoscopy or laparotomy)
- Signed informed consent
- Social coverage
- Patient who agrees to be included in the study and who signs the informed consent
form
- Patient affiliated to a healthcare insurance plan
- Patient willing to comply with study's requirements
Exclusion Criteria:
- Need of another type of surgery during the same procedure
- Mentally unbalanced patients, under supervision or guardianship
- Patient who does not understand French/ is unable to give consent
- Patient not affiliated to a French or European healthcare insurance
- Patient incarcerated
Hop Claude Huriez Chu Lille
Lille, France
Robert CAIAZZO, MD,PhD
32044 - +33
robert.caiazzo@chru-lille.fr
Robert CAIAZZO, MD,PhD, Principal Investigator
University Hospital, Lille